位置:首页 > 蛋白库 > AMBE_PSEAE
AMBE_PSEAE
ID   AMBE_PSEAE              Reviewed;        2124 AA.
AC   Q9I1H3;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   03-AUG-2022, entry version 134.
DE   RecName: Full=AMB antimetabolite synthase AmbE {ECO:0000305};
DE            EC=6.2.1.68 {ECO:0000269|PubMed:25814981};
DE   AltName: Full=L-glutamate--[L-glutamyl-carrier protein] ligase {ECO:0000305};
DE   AltName: Full=Nonribosomal peptide synthase AmbE {ECO:0000305};
GN   Name=ambE {ECO:0000303|PubMed:20543073};
GN   OrderedLocusNames=PA2302 {ECO:0000312|EMBL:AAG05690.1};
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=20543073; DOI=10.1128/jb.00492-10;
RA   Lee X., Fox A., Sufrin J., Henry H., Majcherczyk P., Haas D., Reimmann C.;
RT   "Identification of the biosynthetic gene cluster for the Pseudomonas
RT   aeruginosa antimetabolite L-2-amino-4-methoxy-trans-3-butenoic acid.";
RL   J. Bacteriol. 192:4251-4255(2010).
RN   [3]
RP   PROPOSED FUNCTION IN IQS BIOSYNTHESIS, INDUCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=23542643; DOI=10.1038/nchembio.1225;
RA   Lee J., Wu J., Deng Y., Wang J., Wang C., Wang J., Chang C., Dong Y.,
RA   Williams P., Zhang L.H.;
RT   "A cell-cell communication signal integrates quorum sensing and stress
RT   response.";
RL   Nat. Chem. Biol. 9:339-343(2013).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, DOMAIN, AND MUTAGENESIS OF ASP-644;
RP   LYS-1230; SER-1286 AND SER-1819.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=25814981; DOI=10.3389/fmicb.2015.00170;
RA   Rojas Murcia N., Lee X., Waridel P., Maspoli A., Imker H.J., Chai T.,
RA   Walsh C.T., Reimmann C.;
RT   "The Pseudomonas aeruginosa antimetabolite L -2-amino-4-methoxy-trans-3-
RT   butenoic acid (AMB) is made from glutamate and two alanine residues via a
RT   thiotemplate-linked tripeptide precursor.";
RL   Front. Microbiol. 6:170-170(2015).
CC   -!- FUNCTION: Involved in the biosynthesis of the antimetabolite L-2-amino-
CC       4-methoxy-trans-3-butenoic acid (AMB), a non-proteinogenic amino acid
CC       which is toxic for prokaryotes and eukaryotes (PubMed:20543073,
CC       PubMed:25814981). Adenylates L-glutamate and loads it onto its first
CC       peptidyl carrier domain via a thioester linkage to the
CC       phosphopanthetheine moiety (PubMed:25814981). The second peptidyl
CC       carrier domain is loaded with a L-alanine activated by AmbB
CC       (PubMed:25814981). After formation by AmbB of the L-Glu-L-Ala dipeptide
CC       at the first carrier domain of AmbE, the condensation domain of AmbE
CC       probably condenses this dipeptide with the L-Ala residue attached at
CC       the second carrier domain of AmbE to give the L-Ala-L-Glu-L-Ala
CC       tripeptide. The central amino acid, L-Glu, would then undergo a series
CC       of modifications to be converted into AMB while the two flanking L-Ala
CC       residues remain in place (PubMed:25814981). Finally, the L-Ala-AMB-L-
CC       Ala tripeptide is probably released by thioester cleavage via the
CC       thioester domain of AmbE (PubMed:25814981).
CC       {ECO:0000269|PubMed:20543073, ECO:0000269|PubMed:25814981}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + holo-[peptidyl-carrier protein] + L-glutamate = AMP +
CC         diphosphate + L-glutamyl-[peptidyl-carrier protein];
CC         Xref=Rhea:RHEA:62452, Rhea:RHEA-COMP:11480, Rhea:RHEA-COMP:16100,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:64479, ChEBI:CHEBI:144960, ChEBI:CHEBI:456215;
CC         EC=6.2.1.68; Evidence={ECO:0000269|PubMed:25814981};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62453;
CC         Evidence={ECO:0000269|PubMed:25814981};
CC   -!- COFACTOR:
CC       Name=pantetheine 4'-phosphate; Xref=ChEBI:CHEBI:47942;
CC         Evidence={ECO:0000269|PubMed:25814981};
CC   -!- INDUCTION: Expression is regulated by the PhoR-PhoB two-component
CC       system. {ECO:0000269|PubMed:23542643}.
CC   -!- DOMAIN: Modular protein that contains an adenylation domain which
CC       activates the glutamate residue into an aminoacyl-AMP ester, a
CC       methyltransferase domain, a first peptidyl carrier protein domain which
CC       bears a phosphopantetheinyl arm to attach the activated L-glutamate, a
CC       condensation domain involved in the condensation of this amino acid
CC       with a second amino acid bound at the carrier protein domain of another
CC       module, a second peptidyl carrier protein domain which bears a
CC       phosphopantetheinyl arm to attach a L-alanine activated by AmbB and a
CC       thioesterase domain that may release the newly synthesized peptide from
CC       the enzyme. {ECO:0000305|PubMed:25814981}.
CC   -!- DISRUPTION PHENOTYPE: Mutation abolishes AMB production
CC       (PubMed:20543073). Deletion of the gene causes a substantial reduction
CC       in the production of the quorum sensing signal 2-heptyl-3-hydroxy-
CC       4(1H)-quinolone (PQS) (PubMed:23542643). {ECO:0000269|PubMed:20543073,
CC       ECO:0000269|PubMed:23542643}.
CC   -!- SIMILARITY: Belongs to the NRP synthetase family. {ECO:0000305}.
CC   -!- CAUTION: It was suggested by Lee et al that the amb cluster is involved
CC       in the biosynthesis of 2-(2-hydroxyphenyl)-thiazole-4-carbaldehyde
CC       (IQS), a cell-cell communication signal that modulates the production
CC       of AMB through the pqs and rhl quorum sensing systems
CC       (PubMed:23542643). The chemical structure of IQS indicates that this
CC       compound may be assembled from salicylate and cysteine. However,
CC       neither of the two peptide synthases encoded by the amb gene cluster
CC       present adenylation domains with a specificity for these substrates. It
CC       is thus highly implausible that IQS is specified by the amb gene
CC       cluster (PubMed:25814981). {ECO:0000269|PubMed:23542643,
CC       ECO:0000269|PubMed:25814981}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG05690.1; -; Genomic_DNA.
DR   PIR; H83357; H83357.
DR   RefSeq; NP_250992.1; NC_002516.2.
DR   RefSeq; WP_010895606.1; NZ_QZGE01000036.1.
DR   AlphaFoldDB; Q9I1H3; -.
DR   SMR; Q9I1H3; -.
DR   STRING; 287.DR97_6131; -.
DR   ESTHER; pseae-PA2302; Thioesterase.
DR   PaxDb; Q9I1H3; -.
DR   PRIDE; Q9I1H3; -.
DR   EnsemblBacteria; AAG05690; AAG05690; PA2302.
DR   GeneID; 878274; -.
DR   KEGG; pae:PA2302; -.
DR   PATRIC; fig|208964.12.peg.2406; -.
DR   PseudoCAP; PA2302; -.
DR   HOGENOM; CLU_236504_0_0_6; -.
DR   InParanoid; Q9I1H3; -.
DR   OMA; FSEWANE; -.
DR   PhylomeDB; Q9I1H3; -.
DR   BioCyc; MetaCyc:MON-20273; -.
DR   BioCyc; PAER208964:G1FZ6-2341-MON; -.
DR   BRENDA; 6.2.1.68; 5087.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0043604; P:amide biosynthetic process; IEA:UniProt.
DR   GO; GO:1901566; P:organonitrogen compound biosynthetic process; IEA:UniProt.
DR   GO; GO:0044550; P:secondary metabolite biosynthetic process; IEA:UniProt.
DR   Gene3D; 1.10.1200.10; -; 2.
DR   Gene3D; 3.30.300.30; -; 2.
DR   Gene3D; 3.30.559.10; -; 2.
DR   Gene3D; 3.40.50.12780; -; 1.
DR   Gene3D; 3.40.50.150; -; 1.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR010071; AA_adenyl_domain.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR045851; AMP-bd_C_sf.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   InterPro; IPR042099; ANL_N_sf.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR001242; Condensatn.
DR   InterPro; IPR006342; FkbM_mtfrase.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR020802; PKS_thioesterase.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   InterPro; IPR001031; Thioesterase.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF00668; Condensation; 1.
DR   Pfam; PF05050; Methyltransf_21; 1.
DR   Pfam; PF00550; PP-binding; 2.
DR   Pfam; PF00975; Thioesterase; 1.
DR   SMART; SM00823; PKS_PP; 2.
DR   SMART; SM00824; PKS_TE; 1.
DR   SUPFAM; SSF47336; SSF47336; 2.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   TIGRFAMs; TIGR01733; AA-adenyl-dom; 1.
DR   TIGRFAMs; TIGR01444; fkbM_fam; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
DR   PROSITE; PS50075; CARRIER; 1.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 1.
PE   1: Evidence at protein level;
KW   Ligase; Phosphopantetheine; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..2124
FT                   /note="AMB antimetabolite synthase AmbE"
FT                   /id="PRO_0000454846"
FT   DOMAIN          1251..1325
FT                   /note="Carrier 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   DOMAIN          1785..1859
FT                   /note="Carrier 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          456..847
FT                   /note="Adenylation"
FT                   /evidence="ECO:0000305"
FT   REGION          950..1147
FT                   /note="Methyltransferase"
FT                   /evidence="ECO:0000305"
FT   REGION          1359..1780
FT                   /note="Condensation"
FT                   /evidence="ECO:0000305"
FT   REGION          1886..2107
FT                   /note="Thioesterase"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         1286
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         1819
FT                   /note="O-(pantetheine 4'-phosphoryl)serine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MUTAGEN         644
FT                   /note="D->A: Cannot load L-glutamate; when associated with
FT                   T-1230."
FT                   /evidence="ECO:0000269|PubMed:25814981"
FT   MUTAGEN         1230
FT                   /note="K->T: Cannot load L-glutamate; when associated with
FT                   A-644."
FT                   /evidence="ECO:0000269|PubMed:25814981"
FT   MUTAGEN         1286
FT                   /note="S->A: Cannot load L-glutamate. Mutant loses the
FT                   ability to make AMB."
FT                   /evidence="ECO:0000269|PubMed:25814981"
FT   MUTAGEN         1819
FT                   /note="S->A: Can still load L-glutamate. Mutant loses the
FT                   ability to make AMB."
FT                   /evidence="ECO:0000269|PubMed:25814981"
SQ   SEQUENCE   2124 AA;  229044 MW;  EE5018845F69E93E CRC64;
     MSASEDLQSA VQPAASEALE GFPLSPLQTR AWRRHAERPE NTVVGVRLHA PADPVATLER
     LRRALDGEAQ LRVAYRTMPG MSLPVQVLDG RAADLLVERL PGDGDWAGRF ARESARLAAS
     PLGGEGQPVL ALGLLLDAAG ETLQGLLLAA PAFVVDAASL VALLRRGLGP AGQASADEGD
     EALLFQHFSE WANEALAGED GESASGYWRE QAAVAAESPL ALADDLGEGE WTARRLLPRA
     LLERLAANGL PEAAALLAWT QVAGQFQGDE GLPLEMARLV SGRLFNEFAE LAGPFAGVAP
     LCLENVRAGS VGERLDALQA AILAQEEAAA LRDPFAPDWP LAELGFAWLA GELDGAGVAE
     LDCRQPPLGG FLELQVLPHG EGRLASLRVR RDHDGTLAGR LLDAWVECLE SIAADRQLPL
     AGLPLIGAAE RERYQAWQGE RVEPAPVESL VAAFDLRAAL QPQAPALLDA HGSLDFATLR
     ARSEAVAEAL LAAGVRPGQA VAVMTGRNRE AIVALLGVMR AAAVYTPVNP EFPAARVERM
     REAGGIVFAL ADAECAGRAR EAFAGACLDL STLPLAGSGM SLPAPGGRDA AYMIFTSGTS
     GQPKGVVVEH ASALNLSQAL ARTVYANVVG EGLRVTVNAP FSFDSSIKQI LQLLSGHCLV
     LVPQEVRSDP QRMLGFLEER RIDVLDCTPS LFRLLLQAGL DDAHPALPGR ILVGGERFDE
     ASWEVAAGWR RCQVFNLYGP TEATVNASLA RVAEHARPTI GRALANVDLH VVDGLGRRKT
     RGASGELWIG GAGVARGYAG DAGEAAGRFV EEGWPGSGRL YRSGDLVRWR ADGCLEFLGR
     IDEQVKINGY RIELGEIRSA LLEHPAVGEA AVLTDEADAA EPGADRRIVA FVTAAEETAD
     ESWLEVDLPS GHRVAGLNLN ETEYVYQEIF VDEVYSRDGI VLPPDAVVLD VGANIGLFSL
     YIASRAPRAR VVAFEPLAPI RRRLEANLGR YAPQVEVFGI GLSDAEREET FTYYPGYSTF
     SGIAEYADAS GERDVIRRYL SNQGEEGGAN LLLDNIDEIL DDRLRAEAHR CRLRRLDQVI
     GELGLERIDL LKIDVQRAEM DVLLGLDDAA LAKVRQIVLE VHDKRDGATA GRADALSDLL
     RRHGFEVSIR QDALLEGTDR YNCYAVRPGY AESLAERIDW RALAPRPAAA LGGELSEQAL
     RGFLEARLPA YMLPSRIARV ERLPLTAEGK LDRRALLAAL AAEAAAQTLE APANATEAAL
     LEIWKSVLKR PAIGVSDNFF QVGGDSIRLI QMQVMAREAG LAFTLRDVFN HQSIRELARL
     LAAPASPADA LGTSAPQSLE PFALLSAAER KRLPEGLDDA YPMTSLQQGM LLQSEASGDP
     RLLHNVVLHE VHGRLDGELL ARAWAILIGR HAILRTGFDL HGGQVPLQWV HPATAVAAEV
     PVHDLCGLDG ETRRLRLRAW IEEEQATPFD WSRPPLVRLA ALALDERRFA LGVAEHHSVL
     DGWSLQSLVD ELLAVYADLL AGVVAREAEA PAVGFRDYVA LEREAEANAA SALFWLDYLA
     GARYRPLPGL AEEGPRRMAA VRVDVPADSL SRLRALAERS GLPLRSLLLA AHGRALCRFS
     DADEVVTGFV SHGRPEEPGA DRLLGLFLNT LPCRLSASVD LLDSARRAFD YERASLEHRR
     HPLAAIRRRN RELRLDSLFN FVDFHQDDAA PAGVRHGGIL DQVVVDVDVP LAVDFEVAGE
     RLEVGFQYAA GRFPAERAEA LAGAYREALL ALLGDPVQPP AAAQAEDSVE LRRVLKVLSR
     VLGRPLAADQ GFASAGGHSL LGVQAIAELR RLTGRQLSLG LLQGDPDARE VVRRCHAADA
     PPLPPATERA RALWLQRSGS AQPRLRLIAL PPAGGNAGTF RGWDARLPAD VELLAIQYPG
     RQERQDEPFV TDVEAMLCAI DDALLPLLDR PFALIGASLG GMLAYELAAR LESLHGLRAR
     QLFVISSRAP GPDLEYPRFH AMGDAELLRT LREYDVLPLE VLDDPELREI SLATLRADSR
     LAADYRYRPR EPLAIPITAI LGEQDPGVSR VAIDGWRRHA SRYELETLAG GHGLVVTAAE
     EVCAILRQRL APDVPGGVPA NLAT
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024